Results 131 to 140 of about 43,962 (233)

A 12-year expanding pink plaque on the chest. [PDF]

JAAD Case Rep
Etaee F, Castiglione F, Jiang X, Hu R, Galan A, Choate KA, Vesely MD.   +6 more
europepmc   +1 more source

Evaluating isoprenol production using the IPP-bypass pathway in the oleaginous yeast Rhodosporidium toruloides. [PDF]

Biotechnol Biofuels Bioprod
Garcia VE, Geiselman GM, Hwang HJ, Chen Y, Gin JW, McFadden-Mitchell J, Montgomery V, Kakumanu R, Goswami S, McCauley J, Adamczyk PA, Baidoo EEK, Petzold CJ, Simmons BA, Lee TS, Gladden JM.   +15 more
europepmc   +1 more source

Case Report: Clinical application of an <i>in vitro</i> prenylation assay in the diagnosis of an early-onset case of mevalonate kinase deficiency harbouring a novel <i>MVK</i> variant. [PDF]

Front Pediatr
Burleigh A, Kul Cinar O, Torpiano P, Munoz MA, Abell-King C, Rogers MJ, Eleftheriou D, Brogan PA.   +7 more
europepmc   +1 more source

Identification of two novel <i>MVD</i> mutations and one novel <i>FDPS</i> mutation in Chinese patients with porokeratosis. [PDF]

Front Med (Lausanne)
He Y, Zhu S, Wei Q, Ye F, Zhu Y, Ouyang X, Wu L, Li C.   +7 more
europepmc   +1 more source

Lipophilic Statins Deplete GPX4 to Promote Ferroptosis and Sensitize Cancer Cells to Immune Checkpoint Blockade. [PDF]

Mol Cancer Ther
Talty R, Brooks VT, McGeary MK, Milette S, Zheng S, Flem-Karlsen K, Daniels A, Deshmukh M, Park K, Caraccio W, Yan H, Echeandia-Francis C, McNamara M, Hong S, Kirwin DS, Olino K, Johnson CH, Bosenberg M, Micevic G, Roy SF.   +19 more
europepmc   +1 more source

Harnessing evolution: leveraging bacterial isoprenoid pathway diversity toward improved bioengineering strategies. [PDF]

J Bacteriol
Qabar CM, Marshall BA, Landick R, Cox JS.   +3 more
europepmc   +1 more source

From a Gene Mutation to Pathology and Targeted Therapy in a Patient with Therapy-resistant Porokeratosis. [PDF]

Acta Derm Venereol
Möller M, Elsharkawi-Welt K, Klehr-Martinelli M, Siebert R, Scharffetter-Kochanek K.   +4 more
europepmc   +1 more source

Mevalonic acid exerts procoagulant effect by potentiating factor Xa. [PDF]

Nat Prod Bioprospect
Niu L, Liu C, Wang S, Yin Q, Lin S, Yan M, Li W, Yin Y, Wang W, Yu W, Tang X, Xue M, Wang Y.   +12 more
europepmc   +1 more source

Case Report: Mevalonate kinase deficiency: an underdiagnosed cause of ischemic stroke-characterization of a novel genetic variant. [PDF]

Front Immunol
Hamidi LN, Drda JC, Belhocine M, Elfassy HL, Ducharme-Bénard S, Chayer-Lanthier M, Sultana B, Lanthier S.   +7 more
europepmc   +1 more source

THE BIOSYNTHESIS OF MEVALONIC ACID [PDF]

Proceedings of the National Academy of Sciences, 1959
J J, Ferguson, I F, Durr, H, Rudney
openaire   +2 more sources